Senior Director of Product Development, Brian Lankadurai, PhD, explains how CPL delivers a truly integrated, end‑to‑end approach to topical drug development. By uniting formulation scientists, analytical experts, and Skin Lab specialists under one roof, CPL reduces development risk, shortens timelines, and ensures scalability from early formulation through commercial manufacturing. Real‑world examples highlight how in‑house IVPT testing and formulation screening work together to rapidly identify stable, effective products that reach the intended skin layer.